Melatonin counteracts the loss of agonist-evoked contraction of aortic rings induced by incubation

Fundamental and Clinical Pharmacology

Volumn 21, Issue 3, 2007, Pages 273-279

  Lartaud, Isabelle ^a   Faure, Sébastien ^a,c   Tabellion, Aurore ^a   Resende, Angela C ^a,d   Nadaud, Sophie ^b   Bagrel, Denyse ^a   Capdeville Atkinson, Christine ^a   Atkinson, Jeffrey ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b INSERM   (France)

^c Universite d'Angers   (France)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Aortic wall; Incubation; iNOS; Melatonin; Vasoconstriction

Indexed keywords

ANTIOXIDANT; CATALASE; INDUCIBLE NITRIC OXIDE SYNTHASE; LUZINDOLE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; NORADRENALIN; RECEPTOR BLOCKING AGENT;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EVOKED RESPONSE; INCUBATION TIME; ISOLATED ARTERY; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THORACIC AORTA; VASCULAR RING; WISTAR RAT;

ANIMALS; AORTA, THORACIC; CATALASE; CULTURE MEDIA; GLUTATHIONE PEROXIDASE; MALE; MELATONIN; NITRIC OXIDE SYNTHASE TYPE II; NOREPINEPHRINE; RATS; RATS, WISTAR; RNA, MESSENGER; VASOCONSTRICTOR AGENTS;

EID: 34249048182     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2007.00484.x     Document Type: Article

References (37)

1. Viswanathan M., Laitinen J.T., Saavedra J.M. Expression of melatonin receptors in arteries involved in thermoregulation. Proc. Natl Acad. Sci. U.S.A. (1990) 87 6200 6203.
2. Ekmekcioglu C., Thalhammer T., Humpeler S. et al. The melatonin receptor subtype MT2 is present in the human cardiovascular system. J. Pineal Res. (2003) 35 40 44.
3. Viswanathan M., Scalbert E., Delagrange P., Guardiola-Lemaitre B., Saavedra J.M. Melatonin receptors mediate contraction of a rat cerebral artery. Neuroreport (1997) 8 3847 3849.
4. Geary G.G., Krause D.N., Duckles S.P. Melatonin directly constricts rat cerebral arteries through modulation of potassium channels. Am. J. Physiol. Heart Circ. Physiol. (1997) 273 H1530 H1536.
5. Ting K.N., Dunn W.R., Davies D.J. et al. Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the tail artery of juvenile Wistar rats. Br. J. Pharmacol. (1997) 122 1299 1306.
6. Régrigny O., Delagrange P., Scalbert E., Lartaud-Idjouadiene I., Atkinson J., Chillon J.M. Effects of melatonin on rat pial arteriolar diameter in vivo. Br. J. Pharmacol. (1999) 127 1666 1670.
7. Vandeputte C., Giummelly P., Atkinson J., Delagrange P., Scalbert E., Capdeville-Atkinson C. Melatonin potentiates NE-induced vasoconstriction without augmenting cytosolic calcium concentration. Am. J. Physiol. Heart Circ. Physiol. (2001) 280 H420 H425.
8. Yang Q., Scalbert E., Delagrange P., Vanhoutte P.M., O'Rourke S.T. Melatonin potentiates contractile responses to serotonin in isolated porcine coronary arteries. Circ. Am. J. Physiol. Heart. Physiol. (2001) 280 H76 H82.
9. Sener G., Kapucu C., Paskaloglu K. et al. Melatonin reverses urinary system and aorta damage in the rat due to chronic nicotine administration. J. Pharm. Pharmacol. (2004) 56 359 366.
10. Reiter R.J. Antioxidant actions of melatonin. Adv. Pharmacol. (1997) 38 103 117.
11. Cuzzocrea S., Reiter R.J. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur. J. Pharmacol. (2001) 426 1 10.
12. Kim S.J., Reiter R.J., Qi W., Tan D., Cabrera J. Melatonin prevents oxidative damage to protein and lipid induced by ascorbate-Fe(3+)-EDTA: comparison with glutathione and alpha-tocopherol. Neuroendocrinol. Lett. (2000) 21 269 276.
13. Cernadas M.R., Sanchez de Miguel L., Garcia-Duran M. et al. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ. Res. (1998) 83 279 286.
14. Csiszar A., Ungvari Z., Edwards J.G. et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ. Res. (2002) 90 1159 1166.
15. Tran N.N., Spitzbarth E., Robert A., Giummelly P., Atkinson J., Capdeville-Atkinson C. Nitric oxide lowers the calcium sensitivity of tension in the rat tail artery. J. Physiol. (1998) 507 163 174.
16. Capdeville-Atkinson C., Oster L., Thorin Trescases N., Robert A., Corman B., Atkinson J. Effect of chronic ANG I-converting enzyme inhibition on aging processes. V. Intracellular calcium-vasoreactivity coupling. Am. J. Physiol. (1995) 268 R1394 R1400.
17. Robert A., Tran N.N.P., Giummelly P., Atkinson J., Capdeville-Atkinson C. Sensitivity of norepinephrine-evoked vasoconstriction to pertussis toxin in the old rat. Am. J. Physiol. (1998) 274 R1604 R1612.
18. Tabernero A., Nadaud S., Corman B., Atkinson J., Capdeville-Atkinson C. Effects of chronic and acute aminoguanidine treatment on tail artery vasomotion in ageing rats. Br. J. Pharmacol. (2000) 131 1227 1235.
19. Resende A.C., Tabellion A., Nadaud S. et al. Incubation of rat aortic rings produces a specific reduction in agonist-evoked contraction: effect of age of donor. Life Sci. (2004) 76 9 20.
20. Zhou J.L., Zhu X.G., Ling Y.L., Li Q. Melatonin reduces peroxynitrite-induced injury in aortic smooth muscle cells. Acta Pharmacol. Sin. (2004) 25 186 190.
21. Dubocovich M.L. Luzindole (N-0774): a novel melatonin receptor antagonist. J. Pharmacol. Exp. Ther. (1988) 246 902 910.
22. Caplan B.A., Gerrity R.G., Schwartz C.J. Endothelial cell morphology in focal areas of in vivo Evans blue uptake in the young pig aorta. Exp. Mol. Pathol. (1974) 21 102 117.
23. Challah M., Nadaud S., Philippe M. et al. Circulating and cellular markers of endothelial dysfunction with aging in rats. Am. J. Physiol. Heart Circ. Physiol. (1997) 273 H1941 H1948.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. (1951) 193 265 275.
25. Beers R.F., Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. (1951) 95 133 140.
26. Carmagnol F., Sinet P.M., Jerome H. Selenium-dependent and non-selenium-dependent glutathione peroxidases in human tissue extracts. Biochim. Biophys. Acta (1983) 759 49 57.
27. Bolz S.S., Vogel L., Sollinger D. et al. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation (2003) 107 3081 3087.
28. Spitzbarth-Regrigny E., Petitcolin M.A., Bueb J.L., Tschirhart E.J., Atkinson J., Capdeville-Atkinson C. Pertussis toxin-sensitive G(i)-proteins and intracellular calcium sensitivity of vasoconstriction in the intact rat tail artery. Br. J. Pharmacol. (2000) 131 1337 1344.
29. Rezzani R., Rodella L.F., Bonomini F., Tengattini S., Bianchi R., Reiter R.J. Beneficial effects of melatonin in protecting against cyclosporine A-induced cardiotoxity are receptor mediated. J. Pineal Res. (2006) 41 288 295.
30. Binko J., Meachem S., Majewski H. Endothelium removal induces iNOS in rat aorta in organ culture, leading to tissue damage. Am. J. Physiol. (1999) 276 E125 E134.
31. Bishop-Bailey D., Larkin S.W., Warner T.D., Chen G., Mitchell J.A. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br. J. Pharmacol. (1997) 121 125 133.
32. Kleschyov A.L., Muller B., Keravis T., Stoeckel M.E., Stoclet J.C. Adventitia-derived nitric oxide in rat aortas exposed to endotoxin: cell origin and functional consequences. Am. J. Physiol. Heart Circ. Physiol. (2000) 279 H2743 H2751.
33. Poderoso J.J., Carreras M.C., Lisdero C., Riobo N., Schopfer F., Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. (1996) 328 85 92.
34. Gunnett C.A., Lund D.D., McDowell A.K., Faraci F.M., Heistad D.D. Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction. Arterioscler. Thromb. Vasc. Biol. (2005) 25 1617 1622.
35. Majewski H., Dziwinski T., Pawlak J., Waloch M., Skwarlo-Sonta K. Anti-inflammatory and opioid-mediated effects of melatonin on experimental peritonitis in chickens. Life Sci. (2005) 76 1907 1920.
36. Escames G., Lopez L.C., Ortiz F., Ros E., Acuna-Castroviejo D. Age-dependent lipopolysaccharide-induced iNOS expression and multiorgan failure in rats: effects of melatonin treatment. Exp. Gerontol. (2006) 41 1165 1173.
37. Atkinson J. Cardiovascular ageing. Physiology, pathology, pharmacology and therapeutics. Cardiovasc. Drug Rev. (1998) 16 300 311.